HEADER TRANSFERASE 20-MAR-06 2GEU
TITLE PANTOTHENATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS (MTPANK) IN
TITLE 2 COMPLEX WITH A COENZYME A DERIVATIVE, FORM-II (RT)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PANTOTHENATE KINASE;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: PANK, PANTOTHENIC ACID KINASE;
COMPND 5 EC: 2.7.1.33;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS;
SOURCE 3 ORGANISM_TAXID: 83332;
SOURCE 4 STRAIN: H37RV;
SOURCE 5 GENE: COAA(RV1092C);
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A(+) (NOVAGEN)
KEYWDS HOMODIMER, COA BIOSYNTHESIS, NUCLEOTIDE BINDING, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN
REVDAT 6 23-OCT-24 2GEU 1 REMARK
REVDAT 5 25-OCT-23 2GEU 1 REMARK SEQADV LINK
REVDAT 4 18-OCT-17 2GEU 1 REMARK
REVDAT 3 13-JUL-11 2GEU 1 VERSN
REVDAT 2 24-FEB-09 2GEU 1 VERSN
REVDAT 1 06-JUN-06 2GEU 0
JRNL AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN
JRNL TITL INVARIANCE AND VARIABILITY IN BACTERIAL PANK: A STUDY BASED
JRNL TITL 2 ON THE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK.
JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 628 2006
JRNL REFN ISSN 0907-4449
JRNL PMID 16699190
JRNL DOI 10.1107/S0907444906012728
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN
REMARK 1 TITL EXPRESSION, PURIFICATION, CRYSTALLIZATION AND PRELIMINARY
REMARK 1 TITL 2 X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PANTOTHENATE KINASE FROM
REMARK 1 TITL 3 MYCOBACTERIUM TUBERCULOSIS
REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 61 65 2005
REMARK 1 REFN ESSN 1744-3091
REMARK 1 PMID 16508093
REMARK 1 DOI 10.1107/S1744309104028040
REMARK 2
REMARK 2 RESOLUTION. 2.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.57
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1379977.980
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9
REMARK 3 NUMBER OF REFLECTIONS : 13506
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.183
REMARK 3 FREE R VALUE : 0.221
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 685
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 10
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1266
REMARK 3 BIN R VALUE (WORKING SET) : 0.3170
REMARK 3 BIN FREE R VALUE : 0.3660
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 75
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.042
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2448
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 52
REMARK 3 SOLVENT ATOMS : 86
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 72.20
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.20
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 8.25000
REMARK 3 B22 (A**2) : 8.25000
REMARK 3 B33 (A**2) : -16.50000
REMARK 3 B12 (A**2) : 14.65000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31
REMARK 3 ESD FROM SIGMAA (A) : 0.47
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.52
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : GROUP
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.27
REMARK 3 BSOL : 34.55
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP+CME.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : DRGCNS_COA_2ME.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN+CME.TOP
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2GEU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-06.
REMARK 100 THE DEPOSITION ID IS D_1000037030.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 16-MAY-04
REMARK 200 TEMPERATURE (KELVIN) : 293.0
REMARK 200 PH : 6.50
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : OSMIC MIRROR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, CCP4 (TRUNCATE)
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13523
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900
REMARK 200 RESOLUTION RANGE LOW (A) : 19.570
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : 0.08800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7
REMARK 200 DATA REDUNDANCY IN SHELL : 4.70
REMARK 200 R MERGE FOR SHELL (I) : 0.53600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ID 1ESM
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 69.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.10
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15%(W/V) PEG8000, 0.05M NACL, 0.05
REMARK 280 -0.1M NAOAC IN 0.1 M NA-CACODYLATE BUFFER OF PH 6.5, 0.001M BETA-
REMARK 280 MERCAPTOETHANOL WAS PRESENT IN THE PROTEIN BUFFER, PH 6.50,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z+2/3
REMARK 290 6555 -X,-X+Y,-Z+1/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.95000
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 59.90000
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 59.90000
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.95000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE FOLLOWING SYMMETRY OPERATION WILL GENERATE THE SECOND
REMARK 300 SUBUNIT OF THE HOMODIMERIC MTPANK MOLECULE: SYMMETRY:-X, -X+Y, -Z+1/
REMARK 300 3; TRANSSYMM: 765
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA,PQS
REMARK 350 TOTAL BURIED SURFACE AREA: 6950 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 26150 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 161.45100
REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 93.21378
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 29.95000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 SER A 2
REMARK 465 ARG A 3
REMARK 465 LEU A 4
REMARK 465 GLN A 82
REMARK 465 GLN A 83
REMARK 465 ASN A 84
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 SER A 5 OG
REMARK 470 ARG A 16 CG CD NE CZ NH1 NH2
REMARK 470 GLN A 68 CG CD OE1 NE2
REMARK 470 PRO A 85 CG CD
REMARK 470 ASP A 86 CG OD1 OD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 69 CG - CD - NE ANGL. DEV. = -13.8 DEGREES
REMARK 500 ARG A 69 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU A 6 92.31 175.20
REMARK 500 MET A 23 -132.95 66.44
REMARK 500 SER A 24 58.34 -118.27
REMARK 500 LEU A 78 -7.61 -59.44
REMARK 500 ASP A 86 -9.43 -156.00
REMARK 500 ARG A 116 65.02 -104.45
REMARK 500 ASP A 118 -73.53 -3.69
REMARK 500 HIS A 119 -9.75 -55.83
REMARK 500 HIS A 120 73.61 51.15
REMARK 500 HIS A 194 71.71 19.40
REMARK 500 THR A 245 -90.73 -120.58
REMARK 500 PHE A 254 40.39 -107.60
REMARK 500 PRO A 287 -6.56 -59.22
REMARK 500 HIS A 302 1.25 82.00
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COK A 401
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2GES RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-I (RT)
REMARK 900 RELATED ID: 2GET RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-I (LT)
REMARK 900 RELATED ID: 2GEV RELATED DB: PDB
REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-II
REMARK 900 (LT)
DBREF 2GEU A 1 312 UNP P63810 COAA_MYCTU 1 312
SEQADV 2GEU CME A 173 UNP P63810 CYS 173 MODIFIED RESIDUE
SEQRES 1 A 312 MET SER ARG LEU SER GLU PRO SER PRO TYR VAL GLU PHE
SEQRES 2 A 312 ASP ARG ARG GLN TRP ARG ALA LEU ARG MET SER THR PRO
SEQRES 3 A 312 LEU ALA LEU THR GLU GLU GLU LEU VAL GLY LEU ARG GLY
SEQRES 4 A 312 LEU GLY GLU GLN ILE ASP LEU LEU GLU VAL GLU GLU VAL
SEQRES 5 A 312 TYR LEU PRO LEU ALA ARG LEU ILE HIS LEU GLN VAL ALA
SEQRES 6 A 312 ALA ARG GLN ARG LEU PHE ALA ALA THR ALA GLU PHE LEU
SEQRES 7 A 312 GLY GLU PRO GLN GLN ASN PRO ASP ARG PRO VAL PRO PHE
SEQRES 8 A 312 ILE ILE GLY VAL ALA GLY SER VAL ALA VAL GLY LYS SER
SEQRES 9 A 312 THR THR ALA ARG VAL LEU GLN ALA LEU LEU ALA ARG TRP
SEQRES 10 A 312 ASP HIS HIS PRO ARG VAL ASP LEU VAL THR THR ASP GLY
SEQRES 11 A 312 PHE LEU TYR PRO ASN ALA GLU LEU GLN ARG ARG ASN LEU
SEQRES 12 A 312 MET HIS ARG LYS GLY PHE PRO GLU SER TYR ASN ARG ARG
SEQRES 13 A 312 ALA LEU MET ARG PHE VAL THR SER VAL LYS SER GLY SER
SEQRES 14 A 312 ASP TYR ALA CME ALA PRO VAL TYR SER HIS LEU HIS TYR
SEQRES 15 A 312 ASP ILE ILE PRO GLY ALA GLU GLN VAL VAL ARG HIS PRO
SEQRES 16 A 312 ASP ILE LEU ILE LEU GLU GLY LEU ASN VAL LEU GLN THR
SEQRES 17 A 312 GLY PRO THR LEU MET VAL SER ASP LEU PHE ASP PHE SER
SEQRES 18 A 312 LEU TYR VAL ASP ALA ARG ILE GLU ASP ILE GLU GLN TRP
SEQRES 19 A 312 TYR VAL SER ARG PHE LEU ALA MET ARG THR THR ALA PHE
SEQRES 20 A 312 ALA ASP PRO GLU SER HIS PHE HIS HIS TYR ALA ALA PHE
SEQRES 21 A 312 SER ASP SER GLN ALA VAL VAL ALA ALA ARG GLU ILE TRP
SEQRES 22 A 312 ARG THR ILE ASN ARG PRO ASN LEU VAL GLU ASN ILE LEU
SEQRES 23 A 312 PRO THR ARG PRO ARG ALA THR LEU VAL LEU ARG LYS ASP
SEQRES 24 A 312 ALA ASP HIS SER ILE ASN ARG LEU ARG LEU ARG LYS LEU
MODRES 2GEU CME A 173 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE
HET CME A 173 10
HET COK A 401 52
HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE
HETNAM COK [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-
HETNAM 2 COK (PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-3-
HETNAM 3 COK HYDROXY-4-{[3-({2-[(2-HYDROXYETHYL)
HETNAM 4 COK DITHIO]ETHYL}AMINO)-3-OXOPROPYL]AMINO}-2,2-DIMETHYL-4-
HETNAM 5 COK OXOBUTYL DIHYDROGEN DIPHOSPHATE
HETSYN COK S-(THIOETHYLHYDROXY)COENZYME A
FORMUL 1 CME C5 H11 N O3 S2
FORMUL 2 COK C23 H40 N7 O17 P3 S2
FORMUL 3 HOH *86(H2 O)
HELIX 1 1 ARG A 15 ALA A 20 1 6
HELIX 2 2 LEU A 21 MET A 23 5 3
HELIX 3 3 THR A 30 ARG A 38 1 9
HELIX 4 4 ASP A 45 VAL A 52 1 8
HELIX 5 5 VAL A 52 GLY A 79 1 28
HELIX 6 6 GLY A 102 ARG A 116 1 15
HELIX 7 7 ASP A 129 LEU A 132 5 4
HELIX 8 8 PRO A 134 ASN A 142 1 9
HELIX 9 9 LEU A 143 LYS A 147 5 5
HELIX 10 10 PHE A 149 TYR A 153 5 5
HELIX 11 11 ASN A 154 SER A 167 1 14
HELIX 12 12 MET A 213 PHE A 218 5 6
HELIX 13 13 ARG A 227 MET A 242 1 16
HELIX 14 14 PHE A 254 ALA A 258 5 5
HELIX 15 15 SER A 261 ILE A 276 1 16
HELIX 16 16 ILE A 276 ASN A 284 1 9
HELIX 17 17 ILE A 285 ALA A 292 5 8
SHEET 1 A 7 TYR A 10 ASP A 14 0
SHEET 2 A 7 ILE A 304 ARG A 310 -1 O LEU A 309 N VAL A 11
SHEET 3 A 7 LEU A 294 LYS A 298 -1 N ARG A 297 O ARG A 306
SHEET 4 A 7 PHE A 220 ASP A 225 1 N ASP A 225 O LYS A 298
SHEET 5 A 7 PHE A 91 GLY A 97 1 N GLY A 94 O LEU A 222
SHEET 6 A 7 ILE A 197 GLU A 201 1 O LEU A 200 N ILE A 93
SHEET 7 A 7 VAL A 123 THR A 127 1 N VAL A 126 O ILE A 199
SHEET 1 B 2 ALA A 172 SER A 178 0
SHEET 2 B 2 ASP A 183 VAL A 192 -1 O VAL A 192 N ALA A 172
LINK C ALA A 172 N CME A 173 1555 1555 1.32
LINK C CME A 173 N ALA A 174 1555 1555 1.33
SITE 1 AC1 24 GLY A 39 LEU A 40 VAL A 99 ALA A 100
SITE 2 AC1 24 LYS A 103 SER A 104 ARG A 108 LYS A 147
SITE 3 AC1 24 TYR A 177 HIS A 179 TYR A 182 LEU A 203
SITE 4 AC1 24 TYR A 235 ARG A 238 MET A 242 PHE A 247
SITE 5 AC1 24 PHE A 254 ILE A 272 ASN A 277 HOH A 501
SITE 6 AC1 24 HOH A 540 HOH A 541 HOH A 544 HOH A 556
CRYST1 107.634 107.634 89.850 90.00 90.00 120.00 P 31 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009291 0.005364 0.000000 0.00000
SCALE2 0.000000 0.010728 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011130 0.00000